EQS-CMS: Fresenius Medical Care AG : Release of a capital market information

Fresenius Medical Care AG: Share buyback

Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014

Share buyback – Interim Report and Final Report

In the period from April 27, 2026 to April 30, 2026 (each inclusive), 354,183 shares were bought back within the framework of the second tranche of the share buyback of Fresenius Medical Care AG, the start of which was disclosed on January 12, 2026, pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No. 596/2014, Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

Shares were bought back as follows:

A total of 10,724,255 shares were acquired within the framework of the second tranche of the share buyback.

The purchase of the shares was carried out by a credit institution commissioned by Fresenius Medical Care AG.

The Company’s share buyback program announced per ad hoc notification of June 17, 2025, has thus been completed. Overall, a total of 24,848,819 shares have been acquired in the period from August 11, 2025 to April 30, 2026. This corresponds to approximately 8.5% of the share capital of Fresenius Medical Care AG.

Fresenius Medical Care AG provides regular information regarding the progress of share buybacks, including by posting its required disclosures at https://freseniusmedicalcare.com/en/investors/shares/share-buyback/.